KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aquestive Therapeutics (AQST) Other Non Operating Income (2019 - 2023)

Historic Other Non Operating Income for Aquestive Therapeutics (AQST) over the last 2 years, with Q4 2023 value amounting to -$1.0 million.

  • Aquestive Therapeutics' Other Non Operating Income changed N/A to -$1.0 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$1.0 million, marking a year-over-year decrease of 19150.14%. This contributed to the annual value of -$1.4 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, Aquestive Therapeutics' Other Non Operating Income is -$1.0 million.
  • In the past 5 years, Aquestive Therapeutics' Other Non Operating Income ranged from a high of -$353000.0 in Q1 2023 and a low of -$4.9 million during Q3 2019